Túlio Maria, Carvalho Liliana, Bana E Costa Tiago, Chagas Cristina
Department of Gastroenterology, Hospital de Egas Moniz, Lisboa, Portugal.
BMJ Case Rep. 2017 May 10;2017:bcr-2017-219768. doi: 10.1136/bcr-2017-219768.
Mixed cryoglobulinemia is frequently secondary to hepatitis C virus infection. Diagnosis and therapeutic management are challenging, depending on the spectrum and severity of manifestations, as well as on the presence of comorbidities. We describe a case of a 79-year-old woman with a non-cirrhotic hepatitis C virus infection presenting with weakness, arthralgias, purpuric rash with left leg ulcerative lesions, bilateral peripheral sensorimotor polyneuropathy, renal impairment and cardiac failure. The investigation was compatible with a severe type II mixed cryoglobulinemia with multisystemic involvement, including a low-grade B cell lymphoma and concomitant intestinal tuberculosis. Initial management with immunosuppressive therapy with glucocorticoids to control symptoms and simultaneous tuberculosis treatment was required. Unavailability of adequate antiviral treatment led to the need to control the severity of systemic manifestations with rituximab, before the effective aetiological treatment with sofosbuvir and ledipasvir was possible, allowing the definitive resolution of the disease.
混合性冷球蛋白血症常继发于丙型肝炎病毒感染。其诊断和治疗管理具有挑战性,这取决于临床表现的范围和严重程度以及合并症的存在情况。我们描述了一例79岁非肝硬化丙型肝炎病毒感染女性患者,其表现为虚弱、关节痛、左腿溃疡性病变的紫癜性皮疹、双侧周围感觉运动性多发性神经病、肾功能损害和心力衰竭。检查结果符合伴有多系统受累的严重II型混合性冷球蛋白血症,包括低度B细胞淋巴瘤和并发肠结核。初始治疗需要使用糖皮质激素进行免疫抑制治疗以控制症状并同时进行抗结核治疗。由于无法获得足够的抗病毒治疗,在使用索磷布韦和来迪帕司韦进行有效的病因治疗成为可能之前,需要使用利妥昔单抗控制全身表现的严重程度,从而使疾病最终得以治愈。